Publication | Closed Access

Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis

InflammationCytokineRelapsing-remitting Multiple SclerosisAutoimmune DiseaseInterleukin-1 Receptor AntagonistMedicineImmunologyImmune RegulationAutoimmunityExploratory Plasma BiomarkerNeurologyImmune FunctionMultiple SclerosisImmunotherapyNeuroimmunologyNeuroinflammation